Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506)

Transplantation

Volumn 65, Issue 5, 1998, Pages 617-619

  Moxey Mims, Marva M ^a   Kay, Cynthia ^a   Light, Jimmy A ^b   Kher, Kanwal K ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KIDNEY TRANSPLANTATION; TACROLIMUS;

EID: 0032521064     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199803150-00003     Document Type: Article

References (17)

1. Starzl TE, Fung J, Jordan M, et al. Kidney transplantation under FK506. JAMA 1990; 264: 63.
2. Schneck FX, Jordan ML, Jensen CWB, et al. Pediatric renal transplantation under FK-506 immunosuppression. J Urol 1992; 147: 1585.
3. Reding R, Wallemacq PE, Lamy ME, et al. Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Transplantation 1994; 57: 93.
4. Ellis D, Shapiro R, Jordan M, et al. Comparison of FK506 and cyclosporine regimens in pediatric renal transplantation. Pediatr Nephrol 1994; 8: 193.
5. Scantlebury V, Shapiro R, Fung J, et al. New onset of diabetes in FK506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc 1991; 23: 3169.
6. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation: FK506 kidney transplant study group. Transplantation 1997; 63: 977.
7. Furth S, Neu A, Colombani P, Plotnick L, Turner ME, Fivush B. Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients. Pediatr Nephrol 1996; 10: 64.
8. McKee M, Segev D, Wise B, et al. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients. J Pediatr Surg 1997; 32: 688.
9. Jindal RM. Posttransplant diabetes mellitus: a review. Transplantation 1994; 58: 1289.
10. Kanzler S, Lohse AW, Schirmacher P, Hermann E, Otto G, Meyer zum Buschenfelde PCH. Complete reversal of FK506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A. Z Gastroenterol 1996; 34: 128.
11. Carroll PB, Rilo H, Reyes J, et al. FK506-associated diabetes mellitus in the pediatric transplant population is a rare complication. Transplant Proc 1991; 23: 3171.
12. Wagner K, Webber SA, Kurland G, et al. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. J Heart Lung Transplant 1997; 16: 275.
13. Odocha O, McCauley J, Scantlebury V, et al. Posttransplant diabetes mellitus in African-Americans after renal transplantation under FK506 immunosuppression. Transplant Proc 1993; 25: 2433.
14. Neylan JF. Racial differences in kidney transplantation: results of a U.S. multicenter, randomized trial [Abstract]. Sixteenth Annual Meeting American Society of Transplant Physicians 1997; 158.
15. Zucker K, Rosen A, Tsaroucha A, et al. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant recipients receiving Prograf and Cellcept in combination therapy. Transplant Proc 1997; 29: 334.
16. Suciu-Foca N, King DW. The HLA system: structure and function. In: Samter M, Talmage DW, Frank MM, Austen KF, Clamen HN, eds. Immunological disease. Boston: Little, Brown, 1988: 395.
17. Tanabe K, Koga S, Takahashi K, et al. Diabetes mellitus after renal transplantation under FK506 (tacrolimus) as primary immunosuppression. Transplant Proc 1996; 28: 1304.